Abstract:Objective In healthy livers, latent transforming growth factor-β (LTGF-β) is stored in the extracellular matrix and kept quiescent by extracellular matrix protein 1 (ECM1). Upon damage, ECM1 is downregulated in hepatocytes, facilitating LTGF-β activation and hepatic fibrosis. This study investigates the underlying molecular mechanisms by which ECM1 expression in the liver is controlled under patho-physiological conditions. Design In silico promoter analysis was used to predict pathways that regulate Ecm1 transcription. Functional assays were performed in AML12 cells, mouse and human primary hepatocytes (MPHs, HPHs), and in liver tissue of mice and patients. Results In healthy liver, EGF/Egfr signaling maintains Ecm1 expression through phosphorylation of Stat1 at S727, which promotes its binding to the Ecm1 gene promoter to enhance gene transcription. During liver inflammation, accumulated IFNγ interferes with EGF signaling by downregulating Egfr expression and by disrupting EGF/Egfr/Stat1-mediated Ecm1 promoter binding. Mechanistically, IFNγ induces Stat1 phosphorylation at position Y701, which is competing with the ability of p-Stat1 S727 to bind to the Ecm1 gene promoter. Additionally, IFNγ induces Nrf2 nuclear translocation and repressive binding to the Ecm1 gene promoter, thus further reducing Ecm1 expression. Importantly, patients suffering from liver cirrhosis who lack nuclear NRF2 expression consistently maintain higher levels of ECM1, inferring a better prognosis. Conclusion ECM1 expression in healthy livers is controlled by EGF/EGFR/STAT1 signaling. Upon liver injury, ECM1 expression is repressed by accumulating IFNγ/NRF2, leading to increased LTGF-β activation and the onset of hepatic fibrosis. ### Competing Interest Statement The authors have declared no competing interest. * ADAMTS1 : A disintegrin and metalloproteinase with thrombospondin motifs 1 BDL : Bile duct ligation CCl4 : Carbon tetrachloride ChIP : Chromatin immunoprecipitation CLD : Chronic liver disease CYP1B1 : cytochrome P450 family 1 subfamily B member 1 ECM1 : Extracellular matrix protein 1 Ecm1- KO : Ecm1 knockout EGF : Epidermal growth factor EGFR : Epidermal growth factor receptor GEO : Gene Expression Omnibus H2O2 : Hydrogen peroxide HBV : Hepatitis-B-virus HCC : Hepatocellular carcinoma HPHs : Human primary hepatocytes HSCs : Hepatic stellate cells IFNγ : Interferon gamma i.p. : Intraperitoneal KEAP1 : Kelch-like ECH-associated protein 1 LTGF-β : Latent TGF-β MELD : Model for End-Stage Liver Disease MMP : Matrix metalloproteinase MPHs : Mouse primary hepatocytes NAFLD : Non-alcoholic fatty liver disease NASH : Non-alcoholic steatohepatitis NQO1 : NAD(P)H:quinone oxidoreductase 1 NRF2 : Nuclear factor erythroid 2-related factor 2 OPZ : Oltipraz qRT-PCR : Quantitative real-time PCR ROS : Reactive oxygen species siRNA : Small interfering RNA S727 : Serine727 TSP-1 : Thrombospondin 1 TSS : Transcription start site Y701 : Tyrosine701

Relationships between Cxcl12, Tweak, Notch1, and Yap mRNA Expression Levels in Molecular Mechanisms of Liver Fibrogenesis

The Annexin A2-Notch Regulatory Loop in Hepatocytes Promotes Liver Fibrosis in NAFLD by Increasing Osteopontin Expression.

Expression Pattern of Matrix Metalloproteinases-13 in a Rat Model of Alcoholic Liver Fibrosis.

Multitranscriptome analyses reveal prioritized genes specifically associated with liver fibrosis progression independent of etiology

The concentration of tumor necrosis factor-α determines its protective or damaging effect on liver injury by regulating Yap activity

(-)-Epigallocatechin-3-gallate and atorvastatin treatment down-regulates liver fibrosis related genes in non-alcoholic fatty liver disease.

Integration of high‑throughput data of microRNA and mRNA expression profiles reveals novel insights into the mechanism of liver fibrosis.

EGF/STAT1 signals to maintain ECM1 expression in hepatic homeostasis are disrupted by IFNγ/NRF2 in chronic liver disease

Integrated Profiling of Long Non-Coding RNAs and Mrnas Identifies Novel Regulators Associated with Liver Fibrosis.

Differential Expression Genes Analyzed by Cdna Array in the Regulation of Rat Hepatic Fibrogenesis

Identification of pivotal genes and crucial pathways in liver fibrosis through WGCNA analysis

Tgfb3 and Mmp13 regulated the initiation of liver fibrosis progression as dynamic network biomarkers

Novel Insights on Notch signaling pathways in liver fibrosis

Identification of TAF1, HNF4A, and CALM2 As Potential Therapeutic Target Genes for Liver Fibrosis

Gene expression profiles of hepatic cell-type specific marker genes in progression of liver fibrosis

Key genes in the liver fibrosis process are mined based on single-cell transcriptomics

IGF2BP3/HIF1A/YAP signaling plays a role in driving acute-on-chronic liver failure through activating hepatocyte reprogramming

Expression of Activins, Follistatin Mrna in the Development of Hepatic Fibrosis

Characteristic Gene Expression in the Liver Monocyte-Macrophage-dc System is Associated with the Progression of Fibrosis in NASH.

Notch signaling mediated by TGF-β/Smad pathway in concanavalin A-induced liver fibrosis in rats

Exploration of Perturbed Liver Fibrosis-Related Factors and Collagen Type I in Animal Model of Non-Alcoholic Fatty Liver Disease